13.10
Precedente Chiudi:
$12.42
Aprire:
$12.58
Volume 24 ore:
1.46M
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.27B
Reddito:
-
Utile/perdita netta:
$-137.25M
Rapporto P/E:
-6.9312
EPS:
-1.89
Flusso di cassa netto:
$-121.97M
1 W Prestazione:
+2.50%
1M Prestazione:
+25.24%
6M Prestazione:
+152.41%
1 anno Prestazione:
+55.21%
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Nome
Oric Pharmaceuticals Inc
Settore
Industria
Telefono
(650) 388-5600
Indirizzo
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Confronta ORIC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ORIC
Oric Pharmaceuticals Inc
|
13.10 | 1.21B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-10-31 | Iniziato | Wells Fargo | Overweight |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-02-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-09-22 | Iniziato | Wedbush | Outperform |
| 2023-03-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Perform |
| 2022-04-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-03-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-22 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-03-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-01-25 | Downgrade | Citigroup | Buy → Neutral |
| 2020-08-13 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-03 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-19 | Iniziato | Citigroup | Neutral |
| 2020-05-19 | Iniziato | Guggenheim | Buy |
| 2020-05-19 | Iniziato | JP Morgan | Overweight |
| 2020-05-19 | Iniziato | Jefferies | Buy |
Mostra tutto
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com
Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
Will ORIC Pharmaceuticals Inc. stock split again soonEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com
How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
Oric Pharmaceuticals, Inc. (ORIC) Investor Outlook: A Promising 47% Upside Potential Amid Innovative Cancer Therapies - DirectorsTalk Interviews
BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now? - sharewise.com
TD Asset Management Inc Raises Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Historical volatility pattern of ORIC Pharmaceuticals Inc. visualizedWeekly Profit Report & Verified Technical Trade Signals - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock todayEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical tools2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
Published on: 2025-10-20 19:38:47 - newser.com
Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):